Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Machine Learning-Based Prognostic Modeling of Thyroid Cancer Recurrence
0
Zitationen
6
Autoren
2026
Jahr
Abstract
Thyroid cancer is the most common type of endocrine cancer. Most cases are called differentiated thyroid cancer (DTC), which includes papillary, follicular, and hurthle cell types. DTC usually grows slowly and has a good prognosis, especially when found early and treated with surgery, radioactive iodine, and thyroid hormone therapy. However, cancer can come back sometimes even years after treatment. This recurrence can appear as abnormal blood tests or as lumps in the neck or other parts of the body. Being able to predict and detect these recurrences early is important for improving patient care and planning follow-up treatment. In this view, this research explores different machine learning algorithms and neural networks to effectively predict DTC recurrence. A total of 17 classifiers were utilized for the experiment, namely, logistic regression, random forest, k-nearest neighbours, Gaussian naïve Bayes, multi-layered perceptron, extreme gradient boosting, adaptive boosting, gradient boosting classifier, extra tree classifier (ETC), light gradient boosting machine, categorical boosting, Bernoulli naïve Bayes, complement naïve Bayes, multinomial naïve Bayes, histogram-based gradient boosting, and nearest centroid, followed by building an artificial neural network. Among the classifiers, ETC performed best with 95.3% accuracy, 95.1% precision, 87.92% recall, 98.18% specificity, 91.21% F1-score, 98.84% AUROC and 97.66% AUPRC on the first dataset, and 99.47% accuracy, 94.83% precision, 98.62% sensitivity, 99.54% specificity, 96.65% F1-score, 99.95% AUROC, and 99.37% AUPRC on the second dataset. To improve model interpretability, Shapley Additive Explanations (SHAP) was also used to explain the contribution of each clinical feature to the model’s predictions, allowing for transparent, patient-specific insights into which factors were most important for predicting recurrence, thereby supporting the proposed model’s clinical relevance.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.061 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.720 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.830 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.348 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.008 Zit.